FLGTFulgent Genetics, Inc.

NAS · US · Healthcare · Diagnostics & Research · fulgentgenetics.com

19.90USD+0.81%Mkt Cap: 547.55M $P/E: —3d ago

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

$44.91BUSDP/E 31.9

IDXX

IDEXX Laboratories, Inc.

Mettler-Toledo International, Inc.

$27.96BUSDP/E 31.5

Labcorp Holdings Inc.

$27.28BUSDP/E 27.8

DGX

Quest Diagnostics Incorporated

$26.97BUSDP/E 26.0

Guardant Health, Inc.

$22.91BUSD

MEDP

Medpace Holdings, Inc.

$17.33BUSDP/E 36.4

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$14.09BUSD

RVTY

Revvity Inc. Common Stock

$13.92BUSDP/E 59.7

ICLR

ICON Public Limited Company

Twist Bioscience Corp.

$9.13BUSD

Key Statistics

Company

Market Cap547.55M $

Enterprise Value295.04M $

Revenue (TTM)323.93M $

Gross Profit130.88M $

Net Income (TTM)-60.51M $

Revenue/Share10.74 USD

Last Price19.90 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees1.3K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS3596641098

Valuation

P/E (Trailing)—

P/E (Forward)-14.43

PEG—

EV/EBITDA-3.30

EV/Revenue0.91

P/S1.69

P/B0.55

EPS (TTM)-2.86

EPS (Forward)-1.38

52W Range

13.4637% of range31.04

52W High31.04 USD

52W Low13.46 USD

Profitability

Gross Margin40.56%

Oper. Margin-39.35%

EBITDA Margin-27.62%

Profit Margin-18.75%

ROE-5.44%

ROA-4.99%

Growth

Revenue Growth4.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF-101.64M $

CapEx (TTM)22.57M $

FCF Margin-28.06%

FCF Yield-16.60%

Net Debt-247.43M $

Net Debt/EBITDA2.77

Balance Sheet

Debt/Equity0.01

Current Ratio6.34

Quick Ratio4.57

Book Value/Sh36.40 USD

Cash/Share9.341 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)19.00 USD

Upside (mean)-4.5%

Target Range19.00 USD – 19.00 USD

# Analysts1

Ownership

Shares Out.27.52M

Float16.69M

Insiders37.81%

Institutions59.29%

Short Interest

Short Ratio9.0d

Short % Float14.97%

Short % Out.9.32%

Shares Short2.57M

Short (prev mo.)2.63M

Technical

SMA 5019.41 (+2.5%)

SMA 20021.06 (-5.5%)

Beta0.91

S&P 52W Chg18.16%

Avg Vol (30d)283.45K

Avg Vol (10d)197.53K

Technical Indicators

RSI (14)57.0

MACD-0.0528

MACD Signal-0.1603

MACD Hist.+0.1076

BB Upper20.74 USD

BB Middle19.00 USD

BB Lower17.25 USD

BB Width18.38%

ATR (14)0.7446 USD

Vol Ratio (20d)1.02x